May 5, 2021
bioRxiv
VGSK Technologies, Inc.
The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
document
budesonide,COVID-19,medical treatments,pharmaceuticals